Cathie Wood's Ark Innovation and Genomic ETFs mark 10 years with mixed performance against S&P 500
Cathie Wood's Ark Funds celebrates the 10th anniversaries of its Ark Innovation ETF (ARKK) and Ark Genomic Revolution ETF (ARKG) on October 31, 2024. ARKK has $5.78 billion in assets and focuses on disruptive innovation, while ARKG has $1.33 billion and targets genomics. Since their launches, ARKK has gained 161.4%, but this lags behind the S&P 500's 10-year return of 13.2%. ARKG has risen 38.9%, also underperforming the S&P 500. Both funds have seen strong growth in earlier years but have struggled recently. The top holdings in ARKK include Tesla and Roku, while ARKG's top holdings feature Twist Biosciences and CRISPR Therapeutics. Despite past successes, both ETFs have faced challenges in maintaining investor interest and performance compared to broader market indices.